Yuhchyau Chen
Overview
Explore the profile of Yuhchyau Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
113
Citations
2403
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Farazi M, Yang X, Gehl C, Barnett G, Burnet N, Chang-Claude J, et al.
Cancer Epidemiol Biomarkers Prev
. 2025 Mar;
PMID: 40029246
Background: Late bladder toxicity is a concern for patients receiving prostate cancer radiotherapy and negatively impacts survivors. Few risk factors are known beyond the radiation dose and volume of bladder...
2.
Zhang Y, Laine A, Iyengar P, Westover K, Dowell J, Hughes R, et al.
Int J Radiat Oncol Biol Phys
. 2025 Feb;
PMID: 39922319
Purpose: We investigated the efficacy and toxicity of thoracic radiation therapy (RT) plus concurrent and consolidation carboplatin with either solvent-based paclitaxel (sb-paclitaxel) or solvent-free nanoparticle albumin-bound paclitaxel (nab-paclitaxel). Methods And...
3.
LeCompte M, Gibbs I, Taparra K, Suneja G, Deville Jr C, White 2nd Z, et al.
Int J Radiat Oncol Biol Phys
. 2024 Jun;
120(4):940-945.
PMID: 38944312
No abstract available.
4.
Lee W, Dignam J, Amin M, Bruner D, Low D, Swanson G, et al.
J Clin Oncol
. 2024 May;
42(20):2377-2381.
PMID: 38759121
JCO NRG Oncology RTOG 0415 is a randomized phase III noninferiority (NI) clinical trial comparing conventional fractionation (73.8 Gy in 41 fractions) radiotherapy (C-RT) with hypofractionation (H-RT; 70 Gy in...
5.
Wefel J, Deshmukh S, Brown P, Grosshans D, Sulman E, Cerhan J, et al.
Int J Radiat Oncol Biol Phys
. 2023 Dec;
119(3):846-857.
PMID: 38101486
Purpose: Whole-brain radiation therapy (WBRT) is a common treatment for brain metastases and is frequently associated with decline in neurocognitive functioning (NCF). The e4 allele of the apolipoprotein E (APOE)...
6.
Sun Y, Tsai Y, Wood R, Shen B, Chen J, Zhou Z, et al.
Int J Radiat Oncol Biol Phys
. 2023 Nov;
119(1):251-260.
PMID: 38008196
Purpose: Genome-wide association studies have identified single-nucleotide polymorphisms (SNPs) associated with radiation therapy (RT) toxicities in patients with prostate cancer. SNP rs17599026 in intron 21 of KDM3B is significantly associated...
7.
Hardy S, Bandyopadhyay S, Yang H, Williams A, Gudina A, Cummings M, et al.
Front Oncol
. 2023 Jul;
13:1111764.
PMID: 37397363
Objectives: Head and neck cancer is a common malignancy frequently treated with chemotherapy and radiotherapy. Studies have shown an increased risk of stroke with the receipt of radiotherapy, but data...
8.
Raldow A, Siker M, Bonner J, Chen Y, Liu F, Metz J, et al.
Adv Radiat Oncol
. 2023 May;
8(5):101210.
PMID: 37152892
Purpose: Advancing equity, diversity, and inclusion in the physician workforce is essential to providing high-quality and culturally responsive patient care and has been shown to improve patient outcomes. To better...
9.
Torous D, Avlasevich S, Bemis J, Howard T, Ware R, Fung C, et al.
Environ Mol Mutagen
. 2023 Feb;
64(3):167-175.
PMID: 36841969
Hydroxyurea is approved for treating children and adults with sickle cell anemia (SCA). Despite its proven efficacy, concerns remain about its mutagenic and carcinogenic potential that hamper its widespread use....
10.
McDonald A, DeMora L, Yang E, Hoyle J, Lenzie A, Williams G, et al.
Cancer
. 2022 Dec;
129(5):685-696.
PMID: 36579470
Purpose: To validate the association between body composition and mortality in men treated with radiation for localized prostate cancer (PCa). Secondarily, to integrate body composition as a factor to classify...